These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9694371)
1. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin. Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371 [TBL] [Abstract][Full Text] [Related]
2. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds. Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin. Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a cytosolic aminopeptidase from Encephalitozoon intestinalis. Millership JJ; Chappell CL; Okhuysen PC; Snowden KF Parasitology; 2002 Jan; 124(Pt 1):1-7. PubMed ID: 11811798 [TBL] [Abstract][Full Text] [Related]
5. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors. Chaudhary M; Singh V; Anvikar AR; Sahi S Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897 [TBL] [Abstract][Full Text] [Related]
6. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors. Sahi S; Raj U; Chaudhary M; Nain V Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653 [TBL] [Abstract][Full Text] [Related]
7. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library. González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898 [TBL] [Abstract][Full Text] [Related]
8. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase. Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860 [TBL] [Abstract][Full Text] [Related]
9. Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors. Cunningham E; Drag M; Kafarski P; Bell A Antimicrob Agents Chemother; 2008 Sep; 52(9):3221-8. PubMed ID: 18458130 [TBL] [Abstract][Full Text] [Related]
10. Purification of a leucine aminopeptidase from Eimeria falciformis. Kaga MM; Laurent F; Doh A; Luffau G; Yvoré P; Péry P Vet Res; 1998; 29(1):107-11. PubMed ID: 9559525 [TBL] [Abstract][Full Text] [Related]
11. Structure- and function-based design of Plasmodium-selective proteasome inhibitors. Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo. Bounaadja L; Schmitt M; Albrecht S; Mouray E; Tarnus C; Florent I Malar J; 2017 Sep; 16(1):382. PubMed ID: 28934959 [TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Babesia bovis M17 Leucine Aminopeptidase and Inhibition of Babesia Growth by Bestatin. Aboge GO; Cao S; Terkawi MA; Masatani T; Goo Y; AbouLaila M; Nishikawa Y; Igarashi I; Suzuki H; Xuan X J Parasitol; 2015 Oct; 101(5):536-41. PubMed ID: 26057618 [TBL] [Abstract][Full Text] [Related]
15. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro. Balmer P; Phillips HM; Maestre AE; McMonagle FA; Phillips RS Parasite Immunol; 2000 Feb; 22(2):97-106. PubMed ID: 10652122 [TBL] [Abstract][Full Text] [Related]
16. Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling. Gavigan CS; Machado SG; Dalton JP; Bell A Antimicrob Agents Chemother; 2001 Nov; 45(11):3175-81. PubMed ID: 11600374 [TBL] [Abstract][Full Text] [Related]
17. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria. Li X; Chen H; Jeong JJ; Chishti AH Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361 [TBL] [Abstract][Full Text] [Related]
18. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1. Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951 [TBL] [Abstract][Full Text] [Related]